|
DDHD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.4076000000024E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.593850E-02 |
| Normal-vs-Stage2 |
1.359570E-01 |
| Normal-vs-Stage3 |
2.06879999797849E-08 |
| Normal-vs-Stage4 |
7.56439999527458E-09 |
| Stage1-vs-Stage2 |
7.812600E-01 |
| Stage1-vs-Stage3 |
2.0759999999953E-05 |
| Stage1-vs-Stage4 |
4.12699999996491E-06 |
| Stage2-vs-Stage3 |
2.022700E-03 |
| Stage2-vs-Stage4 |
2.781800E-03 |
| Stage3-vs-Stage4 |
7.865200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.042070E-04 |
| Normal-vs-AfricanAmerican |
7.220700E-04 |
| Normal-vs-Asian |
1.950430E-01 |
| Caucasian-vs-AfricanAmerican |
8.518600E-01 |
| Caucasian-vs-Asian |
8.593200E-01 |
| AfricanAmerican-vs-Asian |
7.812600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04859999997087E-06 |
| Normal-vs-Female |
1.018350E-02 |
| Male-vs-Female |
3.402300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.083800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.721350E-03 |
| Normal-vs-Age(61-80Yrs) |
2.09419999996907E-06 |
| Normal-vs-Age(81-100Yrs) |
6.136700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.873800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.111400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.422000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.354000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.722600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.400800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.220040E-01 |
| Normal-vs-Grade 2 |
5.323900E-02 |
| Normal-vs-Grade 3 |
1.99679999979274E-07 |
| Normal-vs-Grade 4 |
2.95918844983589E-12 |
| Grade 1-vs-Grade 2 |
2.016100E-02 |
| Grade 1-vs-Grade 3 |
3.56000000000245E-05 |
| Grade 1-vs-Grade 4 |
2.755500E-04 |
| Grade 2-vs-Grade 3 |
1.618730E-04 |
| Grade 2-vs-Grade 4 |
7.21469550768461E-11 |
| Grade 3-vs-Grade 4 |
4.847500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.657400E-01 |
| Normal-vs-ccB subtype |
1.16089999835367E-08 |
| ccA subtype-vs-ccB subtype |
2.49190001966326E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.211300E-04 |
| Normal-vs-N1 |
2.188200E-04 |
| N0-vs-N1 |
8.382500E-02 |
|
|
